Jon B. Klein
Papers
1
Total Citations
41
H-Index
1
About
Dr. Jon B. Klein is a leading investigator in diabetic nephropathy and renal biomarker discovery. His work has fundamentally advanced the understanding of how molecular markers can predict progressive kidney disease, particularly in type 1 diabetes. Dr. Klein’s most-cited study, "Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes" (2013, 41 citations), identified specific kininogen fragments as early indicators of renal decline, offering a non-invasive tool for risk stratification. This contribution is pivotal for clinicians seeking to intervene before irreversible damage occurs. Beyond this landmark paper, Dr. Klein’s research integrates proteomics and clinical nephrology, bridging bench-to-bedside translation. His work has been recognized for its potential to personalize treatment for diabetic patients, reducing the burden of end-stage renal disease. For students and researchers, Dr. Klein exemplifies how targeted biomarker studies can transform chronic disease management, providing a roadmap for early detection and precision medicine in nephrology.
Research Focus
Key Achievements
Top Papers
- 1